section name header

Y-Site Injection Compatibility (1:1 Mixture)

Blinatumomab

(Mfr: AMG)(Conc: 0.125 and 0.375 mcg/mLb)

QMark

Daptomycin

(Mfr: MSD)(Conc: 6.1 mg/mLb)

Remarks:

Particles, flakes, thin needles, or haze transiently appears

Ref:

3405,3417